Cholic Acids
"Cholic Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholanic acid family of bile acids in man, usually conjugated with glycine or taurine. They act as detergents to solubilize fats for intestinal absorption, are reabsorbed by the small intestine, and are used as cholagogues and choleretics.
Descriptor ID |
D002793
|
MeSH Number(s) |
D04.210.500.105.225 D04.210.500.221.430
|
Concept/Terms |
Cholic Acids- Cholic Acids
- Acids, Cholic
- Cholalic Acids
- Acids, Cholalic
|
Below are MeSH descriptors whose meaning is more general than "Cholic Acids".
Below are MeSH descriptors whose meaning is more specific than "Cholic Acids".
This graph shows the total number of publications written about "Cholic Acids" by people in this website by year, and whether "Cholic Acids" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 | 1996 | 0 | 1 | 1 | 1998 | 0 | 1 | 1 | 2008 | 1 | 0 | 1 | 2011 | 1 | 0 | 1 | 2015 | 1 | 0 | 1 | 2017 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cholic Acids" by people in Profiles.
-
Wang XX, Wang D, Luo Y, Myakala K, Dobrinskikh E, Rosenberg AZ, Levi J, Kopp JB, Field A, Hill A, Lucia S, Qiu L, Jiang T, Peng Y, Orlicky D, Garcia G, Herman-Edelstein M, D'Agati V, Henriksen K, Adorini L, Pruzanski M, Xie C, Krausz KW, Gonzalez FJ, Ranjit S, Dvornikov A, Gratton E, Levi M. FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity. J Am Soc Nephrol. 2018 01; 29(1):118-137.
-
Wang XX, Edelstein MH, Gafter U, Qiu L, Luo Y, Dobrinskikh E, Lucia S, Adorini L, D'Agati VD, Levi J, Rosenberg A, Kopp JB, Gius DR, Saleem MA, Levi M. G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes. J Am Soc Nephrol. 2016 05; 27(5):1362-78.
-
Ackerson RM, Shum LC, Berry AR, Bucknell AL, King KB. In vivo model to measure bone repair efficacy of nanoparticle-based drug delivery. Orthopedics. 2014 Aug; 37(8):e707-11.
-
Pfeifer T, Buchebner M, Chandak PG, Patankar J, Kratzer A, Obrowsky S, Rechberger GN, Kadam RS, Kompella UB, Kostner GM, Kratky D, Levak-Frank S. Synthetic LXR agonist suppresses endogenous cholesterol biosynthesis and efficiently lowers plasma cholesterol. Curr Pharm Biotechnol. 2011 Feb 01; 12(2):285-92.
-
Kratzer A, Buchebner M, Pfeifer T, Becker TM, Uray G, Miyazaki M, Miyazaki-Anzai S, Ebner B, Chandak PG, Kadam RS, Calayir E, Rathke N, Ahammer H, Radovic B, Trauner M, Hoefler G, Kompella UB, Fauler G, Levi M, Levak-Frank S, Kostner GM, Kratky D. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia. J Lipid Res. 2009 Feb; 50(2):312-26.
-
Wilson NA, Wolf P, Ploegh H, Ignatowicz L, Kappler J, Marrack P. Invariant chain can bind MHC class II at a site other than the peptide binding groove. J Immunol. 1998 Nov 01; 161(9):4777-84.
-
Matsumura J, Neri K, Rege RV. Hypercholeresis with cholate infusion in dogs with pigment gallstones. Dig Dis Sci. 1996 Feb; 41(2):272-81.
-
Sokol RJ, Winklhofer-Roob BM, Devereaux MW, McKim JM. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology. 1995 Oct; 109(4):1249-56.
-
Everson GT, Fennessey P, Kern F. Contraceptive steroids alter the steady-state kinetics of bile acids. J Lipid Res. 1988 Jan; 29(1):68-76.
-
Suchy FJ, Courchene SM, Balistreri WF. Ontogeny of hepatic bile acid conjugation in the rat. Pediatr Res. 1985 Jan; 19(1):97-101.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|